Hi Richo
During the webinar of 29 Feb 24, Jon mentioned that the bar for the PH and Angelman p-values should be the Phase 3 Rett trial results (2021) and NOT the recent PMS results (as these results were so good, it may set the bar too high). I’ll post a screenshot of the 2021 p-values separately as HC never lets me post text and pics together.
Good luck everyone for the upcoming trial results - especially the patient populations.
Share Price, page-10192
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.65 |
Change
0.000(0.00%) |
Mkt cap ! $1.744B | |||
| Open | High | Low | Value | Volume |
| $13.70 | $13.76 | $13.56 | $3.689M | 270.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 37 | $13.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.66 | 1132 | 2 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |